A sensation of fullness beneath the ribs on the right side A similar feeling under the ribs on the left side Yellowing of the ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.

Italy New molecules/receptors/signaling pathways need to be identified as targets for the generation of new drugs for hepatocellular carcinoma (HCC) therapy. HCCs can be classified into subgroups ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

Scientific Advisory Board formed with internationally recognized liver and biliary tract cancer physicians to support the ...